Healthcare: On the Agenda - Blood drug could aid heart patients

In a nutshell

Bayer Healthcare has published clinical data supporting the potential benefits of its new blood thinning drug Rivaroxaban. The drug could help hundreds of thousands of heart patients who are at risk of blood clots and strokes from irregular heartbeats. Rivaroxaban could replace warfarin - the drug currently used for blood thinning - after a trial showed it had fewer side effects, simplified dosing and higher tolerance.

Who is affected?

Atrial fibrillation (AF) is the most common cardiac rhythm disorder and affects up to six million people in Europe. In patients with AF, an irregular heartbeat makes them vulnerable to the formation of a blood clot in the atria. One-third of AF sufferers will experience a stroke.

What does it mean?

Bayer Healthcare - which developed the anticoagulant drug alongside Johnson & Johnson pharmaceutical - trialled more than 14,000 patients, comparing once-daily Rivaroxaban to dose-adjusted warfarin. The effectiveness of Rivaroxaban was far superior to warfarin, delivering a 21 per cent risk reduction in strokes. The drug also offers simplified dosing.

PR strategy

Bayer Healthcare charged Athena Medical with handling the UK media outreach for the drug.

Coverage

The drug received extensive coverage globally. In the UK, highlights included a three-minute clip on BBC Breakfast, page 13 of the Daily Mail and page 19 of the Daily Mirror.

21% reduced risk of strokes when using Rivaroxaban compared with warfarin

6m people in Europe affected by atrial fibrillation

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

Latest Articles

John Lewis to tell brand story with "tasteful" 150th anniversary celebrations

John Lewis to tell brand story with "tasteful" 150th anniversary celebrations

Department store John Lewis is to use its 150th anniversary this year to talk about its history, which "not enough people know about", according to director of communications Peter Cross.

Labour hires Obama election strategist David Axelrod to fight General Election

Labour hires Obama election strategist David Axelrod to fight General Election

The man who helped Barack Obama win the 2008 and 2012 US presidential elections is to work for Labour along with members of his team.

Sky adds Fever PR to its roster after splitting with Cake

Sky adds Fever PR to its roster after splitting with Cake

Pay-TV giant Sky has added Fever PR to its agency line-up for a wide-ranging brief covering products and services.

Max Clifford trial jury to continue deliberations after Easter break

Max Clifford trial jury to continue deliberations after Easter break

The jury in the trial of celebrity publicist Max Clifford has been sent home for Easter and will reconvene on Tuesday for further deliberations about its verdicts on 11 charges of indecent assault.

Home Office brings in Munro & Forster to campaign against FGM

Home Office brings in Munro & Forster to campaign against FGM

The Home Office has tasked Munro & Forster (M&F) with supporting its campaign to eradicate female genital mutilation (FGM) as part of a wider retained brief.